Published in Addiction on May 08, 2012
Compulsory detention in addiction treatment. Addiction (2013) 1.07
"In their perception we are addicts": social vulnerabilities and sources of support for men released from drug treatment centers in Vietnam. Int J Drug Policy (2014) 0.84
Risk of violence in drug rehabilitation centers: perceptions of people who inject drugs in Tijuana, Mexico. Subst Abuse Treat Prev Policy (2016) 0.83
The effectiveness of compulsory drug treatment: A systematic review. Int J Drug Policy (2015) 0.82
Reviewing harm reduction for people who inject drugs in Asia: the necessity for growth. Harm Reduct J (2015) 0.75
The political and scientific challenges in evaluating compulsory drug treatment centers in Southeast Asia. Harm Reduct J (2017) 0.75
Response to reitan. Addiction (2013) 0.75
"Overconfidence" versus "helplessness": A qualitative study on abstinence self-efficacy of drug users in a male compulsory drug detention center in China. Subst Abuse Treat Prev Policy (2016) 0.75
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci (2011) 11.79
Alcohol and public health. Lancet (2005) 10.82
Time for a change: putting the Transtheoretical (Stages of Change) Model to rest. Addiction (2005) 8.61
Grand challenges in global mental health. Nature (2011) 8.40
The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials. J Subst Abuse Treat (2004) 7.15
Effects of a sustained heroin shortage in three Australian States. Addiction (2005) 6.62
Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA (2002) 6.48
Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet (2012) 6.36
Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. Lancet (2013) 6.19
An invitation to an alcohol industry lobby to help decide public funding of alcohol research and professional training: a decision that should be reversed. Addiction (2004) 5.61
Why evidence for the fetal origins of adult disease might be a statistical artifact: the "reversal paradox" for the relation between birth weight and blood pressure in later life. Am J Epidemiol (2005) 4.81
Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST). Addiction (2008) 3.98
Meta-analysis of drug-related deaths soon after release from prison. Addiction (2010) 3.96
Randomized controlled trial of a web-based computer-tailored smoking cessation program as a supplement to nicotine patch therapy. Addiction (2005) 3.95
Direct-to-consumer genetic testing for addiction susceptibility: a premature commercialisation of doubtful validity and value. Addiction (2012) 3.91
Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction (2011) 3.80
Attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study. Addict Behav (2008) 3.52
Be aware of Drinkaware. Addiction (2013) 3.50
The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study. Psychol Med (2007) 3.45
Addiction, neuroscience and ethics. Addiction (2003) 3.44
The integrity of the science base: a test case. Addiction (2005) 3.40
The Cannabis Youth Treatment (CYT) experiment: rationale, study design and analysis plans. Addiction (2002) 3.36
Reducing harm from alcohol: call to action. Lancet (2009) 3.34
Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction (2008) 3.30
Cannabis use and mental health in young people: cohort study. BMJ (2002) 3.26
Who is responsible for the public's health? The role of the alcohol industry in the WHO global strategy to reduce the harmful use of alcohol. Addiction (2013) 3.24
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med (2009) 3.17
Exploring the association between cannabis use and depression. Addiction (2003) 2.92
Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerström Test for Nicotine Dependence and its components. Addiction (2010) 2.87
Ethical concerns in the community about technologies to extend human life span. Am J Bioeth (2009) 2.87
Development of a taxonomy of behaviour change techniques used in individual behavioural support for smoking cessation. Addict Behav (2010) 2.78
Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction (2014) 2.73
Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci U S A (2006) 2.72
"The evil genius of the habit": DSM-5 seen in historical context. J Stud Alcohol Drugs (2012) 2.70
Heroin overdose: research and evidence-based intervention. J Urban Health (2003) 2.66
Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev (2009) 2.58
A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction (2002) 2.47
Is cannabis use a contributory cause of psychosis? Can J Psychiatry (2006) 2.42
Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials. Nicotine Tob Res (2004) 2.34
Smoking prevalence in England is below 20% for the first time in 80 years. BMJ (2014) 2.31
Gradual Versus Abrupt Smoking Cessation: A Randomized, Controlled Noninferiority Trial. Ann Intern Med (2016) 2.24
Identification of behaviour change techniques to reduce excessive alcohol consumption. Addiction (2012) 2.21
Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug Alcohol Depend (2009) 2.20
Proposals to trial deep brain stimulation to treat addiction are premature. Addiction (2011) 2.17
The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results. Addiction (2003) 2.14
Contingency management for treatment of substance abuse. Annu Rev Clin Psychol (2006) 2.13
Should smokers be offered assistance with stopping? Addiction (2010) 2.07
A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. Drug Alcohol Depend (2003) 2.05
Reducing intoxication among bar patrons: some lessons from prevention of drinking and driving. Addiction (2013) 2.02
Moderators and mediators of a web-based computer-tailored smoking cessation program among nicotine patch users. Nicotine Tob Res (2006) 2.01
Religious beliefs and alcohol control policies: a Brazilian nationwide study. Rev Bras Psiquiatr (2013) 1.99
Heroin-assisted treatment as a response to the public health problem of opiate dependence. Eur J Public Health (2002) 1.89
Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses. Addiction (2002) 1.89
Prevention of relapse after quitting smoking: a systematic review of trials. Arch Intern Med (2006) 1.88
What makes for an effective stop-smoking service? Thorax (2011) 1.87
A compact VEGF signature associated with distant metastases and poor outcomes. BMC Med (2009) 1.84
Lower Risk Cannabis use Guidelines for Canada (LRCUG): a narrative review of evidence and recommendations. Can J Public Health (2011) 1.81
Brief opportunistic smoking cessation interventions: a systematic review and meta-analysis to compare advice to quit and offer of assistance. Addiction (2012) 1.80
Failure to report attempts to quit smoking. Addict Behav (2010) 1.80
Sex differences in subclinical and DSM-IV pathological gambling: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med (2006) 1.79
Cytisine for smoking cessation: a research agenda. Drug Alcohol Depend (2007) 1.70
Patellar resurfacing in total knee arthroplasty: does design matter? A meta-analysis of 7075 cases. J Bone Joint Surg Am (2011) 1.69
Mephedrone: use, subjective effects and health risks. Addiction (2011) 1.69
'The smoking toolkit study': a national study of smoking and smoking cessation in England. BMC Public Health (2011) 1.68
The most "successful" method for failing to quit smoking is unassisted cessation. Nicotine Tob Res (2012) 1.67
Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Arch Gen Psychiatry (2006) 1.66
Factors associated with the use of aids to cessation in English smokers. Addiction (2009) 1.65
Causes of death in a cohort treated for opioid dependence between 1985 and 2005. Addiction (2013) 1.64
Distinct neural circuits support transient and sustained processes in prospective memory and working memory. Cereb Cortex (2008) 1.63
What should be done about mephedrone? BMJ (2010) 1.63
The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain. Pain (2015) 1.62
Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors. Psychopharmacology (Berl) (2010) 1.62
'Real-world' effectiveness of smoking cessation treatments: a population study. Addiction (2013) 1.60
Trajectories of adolescent alcohol and cannabis use into young adulthood. Addiction (2007) 1.60
PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia. Nat Med (2003) 1.60
Assessing smoking status in children, adolescents and adults: cotinine cut-points revisited. Addiction (2008) 1.59
Training family members to manage heroin overdose and administer naloxone: randomized trial of effects on knowledge and attitudes. Addiction (2013) 1.58
Identifying evidence-based competences required to deliver behavioural support for smoking cessation. Ann Behav Med (2011) 1.58
Unplanned quit attempts--results from a U.S. sample of smokers and ex-smokers. Nicotine Tob Res (2009) 1.57
The clinical significance of "small" effects of smoking cessation treatments. Addiction (2007) 1.57
Early dating predicts smoking during adolescence: A prospective study. Addiction (2006) 1.55
Changes in smoking prevalence in 16-17-year-old versus older adults following a rise in legal age of sale: findings from an English population study. Addiction (2010) 1.55
Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies. Int J Drug Policy (2009) 1.53
Self-perceived smoking motives and their correlates in a general population sample. Nicotine Tob Res (2009) 1.53
The distribution of alcohol consumption and the prevention paradox in Brazil. Addiction (2011) 1.53
Testing hypotheses about the relationship between cannabis use and psychosis. Drug Alcohol Depend (2003) 1.49